TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 EUR)
| Closing information | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Turnover |
1,872
|
3,082
|
2,765 |
| Financial expenses |
22
|
18
|
0 |
| Earnings before taxes |
-294
|
29
|
394 |
| EBITDA |
-200
|
200
|
420 |
| Total assets |
2,055
|
1,937
|
3,189 |
| Current assets |
1,476
|
1,278
|
2,818 |
| Current liabilities |
525
|
328
|
408 |
| Equity capital |
1,256
|
1,211
|
2,383 |
| - share capital |
18
|
17
|
20 |
| Employees (average) |
29
|
34
|
2 |
Financial ratios
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Solvency |
61.1%
|
62.5%
|
74.7% |
| Turnover per employee |
65
|
91
|
1,382 |
| Profit as a percentage of turnover |
-15.7%
|
0.9%
|
14.2% |
| Return on assets (ROA) |
-13.2%
|
2.4%
|
12.4% |
| Current ratio |
281.1%
|
389.6%
|
690.7% |
| Return on equity (ROE) |
-23.4%
|
2.4%
|
16.5% |
| Change turnover |
-1,328
|
684
|
-853 |
| Change turnover % | -41% | -24% | |
| Chg. No. of employees |
-5
|
32
|
0 |
| Chg. No. of employees % | -15% | 0% |
Total value of public sale
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.